Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension

American Journal of Cardiology

Volumn 104, Issue 6, 2009, Pages 868-872

  Hampole, Chetan V ^a   Mehrotra, Amit K ^a   Thenappan, Thenappan ^a   Gomberg Maitland, Mardi ^a   Shah, Sanjiv J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; HEMOGLOBIN; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CHILD; CONNECTIVE TISSUE DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ERYTHROCYTE METABOLISM; FEMALE; HEART CATHETERIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RED CELL DISTRIBUTION WIDTH; RISK FACTOR; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ERYTHROCYTE INDICES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 69449099102     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.05.016     Document Type: Article

References (16)

1. McLaughlin V.V., Presberg K.W., Doyle R.L., Abman S.H., McCrory D.C., Fortin T., and Ahearn G. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 78S-92S
2. Levy W.C., Mozaffarian D., Linker D.T., Sutradhar S.C., Anker S.D., Cropp A.B., Anand I., Maggioni A., Burton P., Sullivan M.D., Pitt B., Poole-Wilson P.A., Mann D.L., and Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113 (2006) 1424-1433
3. Pocock S.J., Wang D., Pfeffer M.A., Yusuf S., McMurray J.J., Swedberg K.B., Ostergren J., Michelson E.L., Pieper K.S., and Granger C.B. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27 (2006) 65-75
4. Felker G.M., Allen L.A., Pocock S.J., Shaw L.K., McMurray J.J., Pfeffer M.A., Swedberg K., Wang D., Yusuf S., Michelson E.L., and Granger C.B. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50 (2007) 40-47
5. Tonelli M., Sacks F., Arnold M., Moye L., Davis B., and Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117 (2008) 163-168
6. Thenappan T., Shah S.J., Rich S., and Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 30 (2007) 1103-1110
7. Fijalkowska A., Kurzyna M., Torbicki A., Szewczyk G., Florczyk M., Pruszczyk P., and Szturmowicz M. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 129 (2006) 1313-1321
8. Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol. In press.
9. Felker G.M., Adams Jr. K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
10. Wu A.H., Smith A., Wieczorek S., Mather J.F., Duncan B., White C.M., McGill C., Katten D., and Heller G. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 (2003) 628-631
11. Patel K.V., Ferrucci L., Ershler W.B., Longo D.L., and Guralnik J.M. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 169 (2009) 515-523
12. Perlstein T.S., Weuve J., Pfeffer M.A., and Beckman J.A. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 169 (2009) 588-594
13. Ridker P.M., Rifai N., Clearfield M., Downs J.R., Weis S.E., Miles J.S., and Gotto Jr. A.M. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344 (2001) 1959-1965
14. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., and Ridker P.M. C-reactive protein and the risk of developing hypertension. JAMA 290 (2003) 2945-2951
15. Chiari M.M., Bagnoli R., De Luca P.D., Monti M., Rampoldi E., and Cunietti E. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc 43 (1995) 767-771
16. Pierce C.N., and Larson D.F. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20 (2005) 83-90